Denali Therapeutics, Inc. (DNLI)

17.99 -0.79 (-4.21%) USD  |  NASDAQ  |  Jan 16, 16:00
18.04 +0.05 (+0.28%) After-Hours: 20:00
More

Denali Therapeutics Current Deferred Revenue (Per Share)

Current Deferred Revenue (Per Share) Chart

View Current Deferred Revenue (Per Share) for DNLI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Current Deferred Revenue (Per Share) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Current Deferred Revenue (Per Share) Range, Past 5 Years

View Current Deferred Revenue (Per Share) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Current Deferred Revenue (Per Share) Benchmarks

View Current Deferred Revenue (Per Share) Benchmarks
Start Trial
Enovis Corp. Upgrade
Masimo Corp. Upgrade
Protalix Biotherapeutics, Inc. Upgrade
Twist Bioscience Corp. Upgrade
AIM ImmunoTech, Inc. --